Concentration tests 2021
| Components | Unity | Round 2020.1 | Round 2020.2 | Round 2020.3 | Round 2020.4 |
|---|---|---|---|---|---|
| adalimumab | mg/l | 1,51 | |||
| infliximab | mg/l | 3,92 |
(*) with antibodies
Concentration tests 2020
| Components | Unity | Round 2020.1 | Round 2020.2 | Round 2020.3 | Round 2020.4 |
|---|---|---|---|---|---|
| adalimumab | mg/l | 14,1 | |||
| infliximab | mg/l | 0 * |
(*) with antibodies
Concentration tests 2019
| Components | Unity | Round 2019.1 | Round 2019.2 | Round 2019.3 | Round 2019.4 |
|---|---|---|---|---|---|
| adalimumab | mg/l | 11,31 | 4,95 | 4,2 | 0,01* |
| infliximab | mg/l | 5,62 | 0,03 * | 7,3 | 15,15 |
(*) with antibodies